肿瘤免疫治疗的最新进展与未来前景

Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer.

However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases.

Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods. Kanser, h crelerin kontrols z ekilde o almas ve b y mesi sonucu olu an bir hastal kt r. Erken te his y ntemleri sayesinde bir ok kanser t r nde l m oranlar nda d ya anmaktad r.

Ancak t m d nyada l m nedenleri aras nda kanser, kardiyovask ler hastal klardan sonra halen ikinci s radad r. Bu nedenle, kanser ara t rmalar n n o u kanserden l mleri azaltmak i in daha etkin tedaviler geli tirmeye odaklanm t r. Kanser h cresindeki molek ler mekanizmalar n daha da iyi anla lmas yla kanser tedavisindeki geli meler, zaman i inde geli mi ve de i mi tir.

Ara t rmalar n temel nceli i en y ksek yan t oran na ve en d k yan etkiye sahip tedavi y ntemleri geli tirmektir. mm noterapiler bu ba lamda kanser tedavilerinde yeni bir d nemi ba latm t r. Bu derlemede en ok tercih edilen imm noterapi y ntemlerine yer verilerek yeni nesil tedavi y ntemlerinin gelece ine dair genel bir bak a s sunulmu tur.